Ms contin and Miacalcin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ms contin (morphine sulfate) and Miacalcin (calcitonin, salmon). Common drug interactions include osteomyelitis among females and cellulitis among males.

The phase IV clinical study analyzes what interactions people have when they take Ms contin and Miacalcin. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Ms contin?

Ms contin has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 69,289 Ms contin users. Check the latest studies of Ms contin.

What is Miacalcin?

Miacalcin has active ingredients of calcitonin, salmon. It is often used in osteoporosis. eHealthMe is studying from 5,437 Miacalcin users. Check the latest studies of Miacalcin.



On Jul, 07, 2026

79 people who take Ms contin and Miacalcin together, and have interactions are studied.

Ms contin and Miacalcin drug interactions.

What are the common drug interactions of Ms Contin and Miacalcin, by gender? *:

female:

  1. Osteomyelitis (infection of bone)
  2. Erythema (redness of the skin)
  3. Swelling
  4. Vomiting
  5. Drug dependence
  6. Ear pain
  7. Pneumonia
  8. Weight decreased
  9. Arthropathy
  10. Bone formation increased

male:

  1. Cellulitis (infection under the skin)
  2. Infection
  3. Atelectasis (partial or complete collapse of the lung)
  4. Haematuria (presence of blood in urine)
  5. Lymphadenopathy (disease or enlargement of lymph nodes)
  6. Malnutrition (a condition that results from eating a diet in which certain nutrients are lacking)
  7. Physical disability
  8. Scar
  9. Collapse of lung (functional breakdown of lung)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the common drug interactions of Ms Contin and Miacalcin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Abscess oral (abscess in the mouth)
  2. Alanine aminotransferase increased
  3. Aspartate aminotransferase increased
  4. Bone disorder
  5. Cellulitis (infection under the skin)
  6. Clavicle fracture
  7. Constipation
  8. Dysphagia (a condition in which swallowing is difficult or painful)
  9. Erythema (redness of the skin)
  10. Excessive granulation tissue (excessive collagen-rich tissue which forms at the site of an injury)

50-59:

  1. Depression
  2. Osteonecrosis of jaw (death of bone of jaw)
  3. Metastases to spine (cancer spreads to spine)
  4. Bone disorder
  5. Infection
  6. Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
  7. Osteomyelitis (infection of bone)
  8. Anaemia (lack of blood)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Collapse of lung (functional breakdown of lung)

60+:

  1. Emotional distress
  2. Anxiety
  3. Atelectasis (partial or complete collapse of the lung)
  4. Bone pain
  5. Cellulitis (infection under the skin)
  6. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  7. Chondromalacia (anterior knee pain due to irritation of the cartilage on the under surface of the kneecap)
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Dehydration (dryness resulting from the removal of water)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 15.19%
  2. Stress And Anxiety: 11 people, 13.92%
  3. Breast Cancer Metastatic: 10 people, 12.66%
  4. Pain In Jaw: 9 people, 11.39%
  5. Nerve Compression: 9 people, 11.39%
  6. Breast Cancer Recurrent: 9 people, 11.39%
  7. Breast Cancer: 9 people, 11.39%
  8. Nausea (feeling of having an urge to vomit): 7 people, 8.86%
  9. Migraine (headache): 6 people, 7.59%
  10. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 6.33%

* Approximation only. Some reports may have incomplete information.

Do you take Ms contin and Miacalcin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ms contin and Miacalcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ms contin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Miacalcin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ms contin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Miacalcin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate and calcitonin, salmon (the active ingredients of Ms contin and Miacalcin, respectively), and Ms contin and Miacalcin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: